Conference abstract · 29 Aug 2017
Conference abstractPublished 8 Apr 2013
Expression of estrogen receptor alpha66 and its truncated isoform 36 in thyroid cancer cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The full-length estrogen receptor (ER)-a66 (ERa66) and its truncated isofrom ERa36 have been reported to play roles in the growth of certain human cancers including breast cancer and prostate cancer. However their role in the thyroid cancer is poorly understood. We therefore examined ER-α66 and its isoform ER-α36 in human thyroid cells. We found that ER-α66 was not expressed in normal thyroid cells. In thyroid cancer cells, ER-α66 was weakly expressed or not expressed. However, thyroid cancer cells expressed a significant amount of ER-α36, a novel isoform of ER-α66, at both mRNA and protein levels while this isoform was absent in normal thyroid cells. Overexpression of ER-α66 by ER-α66 DNA transfection enhanced the proliferation and autophagy in thyroid cancer cells. Inhibition of ER-α36 attenuated the proliferation and autophagy in thyroid cancer cells. The increase of phosphorylated ERK but the decrease of Bcl-xL contributed to ER-α-related proliferation and autophagy in cancer cells. Collectively, human normal thyroid cells do not express ER-α66 but cancer cells express ER-α66. A significant amount of ER-α36 is present in thyroid cancer cells but not in normal thyroid cells. ER-α66 promotes the proliferation and autophagy and the inhibition of ER-α36 attenuates both in thyroid cancer cells. The increase of phosphorylated ERK but the decrease of Bcl-xL contributes to ER-α-related proliferation and autophagy. These findings may help to design some target therapies towards ER-α36 in thyroid cancer cells.
Subjects
Biochemistry & BiotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 4 Sep 2013
A comparative immunohistochemical analysis of steroid receptors, basal markers, breast stem cell markers, adhesion molecules and Ki67 expression in primary breast cancer and in lymph node metastases
Research article · 2019
The Relation between Estrogen-positive Receptor in Breast Cancer (ER+) and Obesity in Jeddah
Conference abstract · 29 Mar 2016
Proteomics analysis reveals that HSP70 interacts with estrogen receptor alpha in the nucleus of human breast cancer
Research article · 2019
Antitumor Activity of Atractylenolide II on Breast Cancer Cells through Regulation of Estrogen Receptor Protein Expression and NF-Kb Signaling Pathways
More from this journal
The newest in Metabolomics:Open Access.
Brief report · 29 Dec 2025
Metabolomics Databases Evolve: Broader Scope, Deeper Insights
Perspective · 29 Dec 2025
Metabolomics: Assessing Environmental Health and Risk
Brief report · 29 Dec 2025
Metabolite Quantification: Accuracy, Standards, Applications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMetabolomics:Open Access
- SubjectBiochemistry & Biotechnology
- BylineArticles whose byline prints “George G Chen”
- BylineArticles whose byline prints “Michael D Fan”
- BylineArticles whose byline prints “Alexander C Vlantis”
- BylineArticles whose byline prints “Enders KW Ng”
- BylineArticles whose byline prints “Shirley YW Liu”
- BylineArticles whose byline prints “C Andrew van Hasselt”

